Who we are

The members of VALDIG are medical doctors, biologists and researchers from all parts of Europe and to some extent also from the South America and Asia. See Valdig Centers below. VALDIG members are primarily engaged in Vascular Liver Disease research.

Valdig

Chair
Dr. Virginia Hernandez Gea, Spain

Secretary
Dr. Marco Senzolo, Italy

Vice Secretary
Pr. Laure Elkrief, France

ERN-Liaison
Prof. Aurélie Plessier, France

Steering Committee

Members
Prof. Walter Ageno

Dr Pierre Deltenre

Prof. Valérie McLin

Dr. Michael Praktiknjo

Dr. Bogdan Procopet

Dr Eira Cerda Reyes

VALDIG CENTERS

WESTERN & EASTERN EUROPE

Austria

  • Medical University of Vienna

Belgium

  • University Hospital Gasthuisberg
  • CHIREC
  • CHU Brugmann
  • University Hospital K.U. Leuven
  • Ghent University Hospital

Denmark

  • Odense University Hospital
  • Aarhus University Hospital

France

  • Hospital Jean Bernard, Valenciennes
  • Hospital Beaujon, Paris

Georgia

  • LTD “Salbuni” Referral Center

Germany

  • University Hospital Aachen
  • University of Bonn
  • Martin-Luther-University Halle-Wittenberg
  • University Hospital of Leipzig
  • Klinikum Ludwigsburg
  • University Marburg
  • Medical Center University of Essen

Back to map ↑

Italy

  • University of Bologna
  • Maggiore Hospital, Crema
  • University of Milano
  • Ospedale L. Sacco Milano
  • University Hospital of Padua
  • Umberto I Sapienza University of Roma
  • Ospedale Maggiore Policlinico
  • Universita di Firenze
  • University Hospital Borgo Trento

Romania

  • Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca
  • University of Medicine and Pharmacy, Cluj

Spain

  • Hospital Universitario de Canarias
  • Ramón y Cajal, Madrid
  • Hospital Universitario Central de Asturias (HUCA), Oviedo
  • Gregorio Marañón, Madrid
  • Hospital Universitari i Politecnic la Fe; Valencia
  • Hospital Universitario Puerta de Hierro, Madrid
  • San Pedro de Alcantara, Càceres
  • Hospital Universitari Vall d’Hebron, Barcelona
  • Hospital Clinic Barcelona
  • Parc de Salut Mar
  • Marques de Valdecilla University Hospital

 

      Sweden

      • Karolinska University Hospital, Stockholm

      Switzerland

      • Cantonal Hospital, Baden
      • Inselspital, Bern
      • University Hospital of Geneva
      • CHUV, Lausanne
      • Cantonal Hospital, St. Gallen
      • University Hospital Zürich

      The Netherlands

      • Erasmus University Medical Center, Rotterdam
      • University of Groningen

      United Kingdom

      • Queen Elizabeth Hospital – Liver Unit, Birmingham
      • Royal Free London NHS Trust
      • King’s College Hospital, London

       

      AFRICA & MIDDLE-EAST

      Egypt

      • University of Almansoura

       

      Back to map ↑

      ASIA & PACIFIC

      China

      • Xijing Hospital of Digestive Diseases
      • General Hospital of Shenyang Military Area

      India

      • Seth G S Medical College and K E M Hospital, Mumbai

      Japan

      • Kitasato University, School of Medicine
      • Mishuku Hospital

       

      Back to map ↑

      AMERICAS

      Argentina

      • Hospital Británico de Buenos Aires

       

      Back to map ↑

      Former Chairs

      Pierre-Emmanuel Rautou (MD, PhD) is a clinical specialist in Hepatology with a PhD in vascular biology (2011). He is Professor of Hepatology at Université Paris-Cité and Hôpital Beaujon (Clichy, France) since 2016. He is the head of the splanchnic hemodynamic laboratory at Beaujon Hospital (Clichy, France) since 2012. He is also leading an Inserm team dedicated to the study of the role of vessels in liver diseases, at the INSERM Unit 1149 (Paris Research Center on Inflammation). His research is focused on the role of vessels in liver diseases. Specifically, he is interested in primary vascular liver diseases (portal vein thrombosis and porto-sinusoidal vascular disorder), as well as in vascular involvement in common liver diseases development and complications (extracellular vesicules, coagulation, endothelial cells). He is the chair of the COST EuroVALDINET.

      Andrea De Gottardi is professor and co-head of Gastroenterology and Hepatology at Luzerner Kantonsspital in Lucerne, Switzerland. He leads a research group working on the effects of the intestinal bacterial flora on the regulation of blood flow and portal hypertension. As a researcher-clinician, he contributes to multicentre projects on thrombotic and vascular disorders of the liver and participates in several international studies including the European Reference Network on Rare Liver Diseases He has served as chair of the EASL-VALDIG Consortium and as president of the Swiss Association for the Study of the Liver. He has been co-founder of the Swiss liver patient association and organizes the annual Hepatology-Preceptorship.

      Juan Carlos García-Pagán is a Senior consultant in Hepatology and Head of the Hepatic Hemodynamic section at the Hospital Clinic in Barcelona, Spain and Associate Professor at the University of Barcelona. His main research of Interest include the pathophysiology and treatment of portal hypertension in cirrhosis; treatment of variceal bleeding in patients with cirrhosis, and the natural history and treatment of vascular liver diseases. He was cofounder and former chair until 2019 of the EASL-VALDIG (Vascular liver disease group).

      Dominique Valla is Professor Emeritus of Hepatology at Université Paris-Cité, Assistance Publique-Hôpitaux de Paris and Inserm, He has been the head of the Liver Unit, Hôpital Beaujon. He has been a co-founder and coordinator of the European (EN-Vie and VALDIG) and French (CRMVF) networks for vascular disorders of the liver. His clinical and academic activities, have long been focused on portal hypertension and rare liver diseases, particularly vascular disorders, and later broadened to the diagnosis of NASH in patients with type-2 diabetes.